Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2025-12-25 @ 12:00 AM
NCT ID:
NCT05354258
Eligibility Criteria:
Inclusion Criteria:
* Male and female children aged 1-14 years;
* Provision of a written informed consent by the parent/caregiver and a positive assent by children aged ≥ 12 years (in line with legal regulations in Senegal);
* Willingness to provide finger-prick blood samples, urine, and stool samples;
* Residence in the study area for at least six months
Exclusion Criteria:
* Acutely ill child at the time of the drug administration;
* Child whose parents/caregivers decline to provide consent;
* A known HIV positive child receiving cotrimoxazole prophylaxis;
* A child who has received a dose of any of sulphadoxine-pyrimethamine, amodiaquine, albendazole or praziquantel during the previous six months;
* A child with a known allergy to any of sulphadoxine-pyrimethamine, amodiaquine, albendazole or praziquantel.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
14 Years
Study:
NCT05354258
Study Brief:
Protocol Section:
NCT05354258